$VPHM Recent Headlines Morgan Stanley drops Google from

New Post Public Reply Private Reply Replies (0) Message Board

Nov 18, 2013 at 7:26 PM

$VPHM Recent Headlines

Morgan Stanley drops Google from best idea list 4:25 p.m. Nov. 11, 2013 - Sue Chang
Shire up in London; BSkyB, ITV off after BT soccer deal 12:10 p.m. Nov. 11, 2013 - Sara Sjolin
Strong Chinese data lift European markets 12:09 p.m. Nov. 11, 2013 - Sara Sjolin
Stock futures higher; Twitter, ViroPhama in spotlight 7:54 a.m. Nov. 11, 2013 - Barbara Kollmeyer
ViroPharma surges 26.5% premarket on Shire buyout 7:27 a.m. Nov. 11, 2013 - Ben Eisen
Shire pays $4.2B for rare-disease firm ViroPharma 2:54 a.m. Nov. 11, 2013 - MarketWatch.com
Powerful market uptrend meets seasonal tailwind 11:11 a.m. Nov. 1, 2013 - Michael Ashbaugh
ViroPharma shares soar on news of interest from two overseas buyers 5:09 p.m. Sept. 13, 2013 - Russ Britt
S&P 500 retests its one-decade breakout point 10:37 a.m. June 24, 2013 - Michael Ashbaugh
ViroPharma soars on buyout rumors 1:27 p.m. June 17, 2013 - Russ Britt
Market post-mortem: Big biotechs spike as Street warming to firms 4:43 p.m. April 12, 2013 - Russ Britt
Blood disease medication earns ViroPharma upbeat analyst reviews 12:43 p.m. March 27, 2013 - Russ Britt
Ratings hit three health firms; upgrade helps one 6:12 p.m. Jan. 15, 2013 - Russ Britt
Friday’s biggest gaining and declining stocks 3:14 p.m. Sept. 21, 2012 - Greg Morcroft
ViroPharma gets okay to test reformulated Cinryze 12:09 p.m. Sept. 21, 2012 - MarketWatch.com
Halozyme soars 27% on Cinryze drug update 10:51 a.m. Sept. 21, 2012 - Val Brickates Kennedy
FDA lifts temporary hold on ViroPharma treatment 7:30 a.m. Sept. 21, 2012 - MarketWatch.com
ViroPharma up 15% on FDA nod 2:25 p.m. Aug. 6, 2012 - Val Brickates Kennedy
ViroPharma has FDA nod to expand Cinryze 1:19 p.m. Aug. 6, 2012 - MarketWatch.com
Knight Capital, E-Trade options volumes soar 10:06 a.m. Aug. 2, 2012 - blogs.marketwatch.com

Medicines Co. Gains on QIDP Status - Analyst Blog 1:10 p.m. Nov. 14, 2013 - Zacks.com
Shire PLC Makes For A Promising Investment 12:52 p.m. Nov. 13, 2013 - Seeking Alpha
Shire to Acquire ViroPharma - Analyst Blog 3:53 p.m. Nov. 12, 2013 - Zacks.com
Shire Acquires Viropharma: Two Winners In This Deal 12:55 p.m. Nov. 12, 2013 - Seeking Alpha
Stock Market News for November 12, 2013 - Market News 10:06 a.m. Nov. 12, 2013 - Zacks.com
UPDATE: J.P. Morgan Downgrades ViroPharma Following Announcement of Acquisition by Shire 9:40 a.m. Nov. 12, 2013 - benzinga.com
Benzinga's M&A Chatter for Monday November 11, 2013 5:31 p.m. Nov. 11, 2013 - benzinga.com
ViroPharma Larger Than S&P 500 Component JDS Uniphase 4:39 p.m. Nov. 11, 2013 - TheStreet.com
Shire Buying ViroPharma To Rule Rare Disease Market 4:18 p.m. Nov. 11, 2013 - Investors Business Daily
ViroPharma Gets Bought Out; Medicines Clears Entry 4:13 p.m. Nov. 11, 2013 - Investors Business Daily
Intel Buys ‘Kno’ to Reinforce Education Laptops Sideline and 2 Other Hot Stocks to Watch 11:35 a.m. Nov. 11, 2013 - Wall St. Cheat Sheet
Shire's Growth Carries Swollen Price Tag 11:27 a.m. Nov. 11, 2013 - WSJ.com
Shire Acquiring ViroPharma; Both Stocks Hit Highs 9:57 a.m. Nov. 11, 2013 - Investors Business Daily
Mid-Morning Market Update: Markets Edge Higher; Shire To Acquire ViroPharma For $4.2B 9:37 a.m. Nov. 11, 2013 - benzinga.com
Shire Shells Out $4.2B to Buy ViroPharma 9:15 a.m. Nov. 11, 2013 - FOXBusiness
Morning Market Movers 9:11 a.m. Nov. 11, 2013 - benzinga.com
Shire Buys ViroPharma for $4.2 Billion 8:02 a.m. Nov. 11, 2013 - WSJ.com
Today's Pre-Market Mover With Heavy Volume: ViroPharma (VPHM) 7:48 a.m. Nov. 11, 2013 - TheStreet.com
Shire, Novartis Deals: Pharmaceutical Shakeups Continue 6:55 a.m. Nov. 11, 2013 - 247WallSt.com
Wall Street Breakfast: Must-Know News 6:34 a.m. Nov. 11, 2013 - Seeking Alpha

SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of ViroPharma, Inc. 6:14 p.m. Nov. 14, 2013 - BusinessWire
Acquisitions, Clinical Trial Results and Stock Price Movements - Research Report on ViroPharma, Pfizer, Alkermes, Tenet, and ResMed 8:00 a.m. Nov. 14, 2013 - PR Newswire
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of ViroPharma Incorporated Stockholders 5:11 p.m. Nov. 13, 2013 - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of ViroPharma, Inc. - VPHM 3:15 p.m. Nov. 13, 2013 - PR Newswire
VIROPHARMA INCORPORATED SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 10:57 a.m. Nov. 13, 2013 - BusinessWire
Financial Results, Conference Presentations, Stock Price Update, and Warrant Exercises - Research Report on Halozyme Therapeutics, Oxygen Biotherapeutics, ACADIA, MannKind, and ViroPharma 8:00 a.m. Nov. 13, 2013 - PR Newswire
SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of ViroPharma, Inc. - VPHM 8:28 p.m. Nov. 12, 2013 - PR Newswire
Attention VPHM Shareholders: The Proposed Buyout of ViroPharma Incorporated by Shire plc is under Investigation by The Young Law Firm 1:00 p.m. Nov. 12, 2013 - BusinessWire
LEVI & KORSINSKY, LLP Investigates VIROPHARMA, INC. Board of Directors for Possible Breaches of Fiduciary Duty In Connection With Sale Of Company to Shire PLC 12:53 p.m. Nov. 12, 2013 - BusinessWire
Ryan & Maniskas, LLP Announces Investigation of ViroPharma Inc. 10:49 a.m. Nov. 12, 2013 - PR Newswire
FDA Updates, Corporate Developments: Viropharma, 3D Systems Corporation, Cirrus Logic, Zalicus, The Boeing Company 8:53 a.m. Nov. 12, 2013 - PR Newswire
Analysis of Pivotal Study Data Showed Routine Prevention of Hereditary Angioedema (HAE) Attacks with Cinryze® (C1 esterase inhibitor [human]) Resulted in Improved Health-Related Quality of Life Outcomes Compared to Acute Therapy with C1 Inhibitor While On Placebo 8:00 a.m. Nov. 12, 2013 - PR Newswire
Harwood Feffer LLP Announces Investigation of ViroPharma, Inc. 5:24 p.m. Nov. 11, 2013 - PR Newswire
SHAREHOLDER ALERT: Law Firm Brower Piven Announces Investigation of Possible Breaches of Fiduciary Duty by Directors of ViroPharma Incorporated in Connection with Proposed Buyout 4:09 p.m. Nov. 11, 2013 - BusinessWire
Finkelstein Thompson LLP Announces Investigation of ViroPharma Inc. Buyout Proposal 3:23 p.m. Nov. 11, 2013 - BusinessWire
VIROPHARMA INCORPORATED SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 2:33 p.m. Nov. 11, 2013 - BusinessWire
ViroPharma Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Shire 12:17 p.m. Nov. 11, 2013 - BusinessWire
LEVI & KORSINSKY, LLP Investigates VIROPHARMA, INC. Board of Directors for Possible Breaches of Fiduciary Duty In Connection With Sale Of Company to Shire PLC 11:15 a.m. Nov. 11, 2013 - BusinessWire
VIROPHARMA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of ViroPharma Inc. (VPHM) Over the Proposed Sale of the Company to Shire (SHPG) in a Cash Deal 11:14 a.m. Nov. 11, 2013 - BusinessWire
Law Firm Brower Piven Announces Investigation of ViroPharma Incorporated Proposed Buyout 11:08 a.m. Nov. 11, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UMC and AP Memory Boost Power with New AI Chips

Breaking Ground in Data Center Power Every so often, the tech industry gets a jolt of innovation that turns heads—not just for what it can do today, but for what it promises tomorrow. This time, it's United Microelectronics Corporation (UMC) and AP Memory shaking things up with their collaboration aimed at redefining power delivery for AI and high-performance computing...

Fosun Drives Global Growth of China's Drug Innovations

A New Phase for Chinese Pharmaceuticals There's a shift in the pharma world, with Fosun International leading the charge. Chinese innovative drugs are stepping onto the global stage, thanks to efforts like those of Chen Qiyu, Co-CEO of Fosun. At the Sustainability Global Leaders Conference 2026, he spoke about transforming Chinese market players into worldwide...

FirstService Ups the Ante with Stylish Jacksonville Office

A New Chapter for FirstService Residential Picture this: a property management powerhouse dialing up their Jacksonville operations with a shiny new office move. FirstService Residential, North America's big shot in property management, has swapped location to a swish setup on Southpoint Drive South in Jacksonville, Florida, aiming to supercharge collaboration and give a...

Verda & Compal Expand AI Infrastructure Globally

AI Infrastructure Takes Center Stage Grab your coffee because Verda and Compal are shaking up the AI scene with their latest announcement from GTC Berlin 2026. The duo's expanding their collaboration, and if you're watching the markets, this isn't something you can ignore. With Verda's AI cloud muscle and Compal's beefed-up global manufacturing, we're talking about a...

Compass Hit by Securities Fraud Suit; Investor Action Urged

Trouble Brewing for Compass Investors Amidst Legal Storm In the tangled web of mergers and acquisitions, Compass, Inc. (NYSE: COMP) finds itself in a legal quagmire that has investors on edge. The stark reality of a securities fraud class action lawsuit has emerged, centered around Compass’s January 2026 merger with Anywhere Real Estate Inc. The Heart of the Allegations...

How Track Rabbit Levels the Playing Field for Small Motorsport Ventures

Fielding Opportunities in a Revved-Up Market You're knee-deep in grease and exhaust, keeping your motorsport enterprise alive against the big dogs without losing grip on the little guy's budget. What if I told you there's a service out there talking your language – combining marketing prowess with AI smarts for as low as $350 a month? That's ALIVE and Track Rabbit...

RavenPack's Data Innovation: Sharpening Financial Analysis

Innovating Financial Analysis with AI They said AI would change everything, but who knew it'd make such a wave in turning research ideas into actionable datasets? RavenPack's latest maneuver is rewriting the playbook. By leveraging a fine-tuned NVIDIA Nemotron model, they've managed to label a mind-boggling 845,220 financial-text excerpts in under an hour. It's not just...

Heineken Hit with €111M Judgment—A Precedent Set

A Brew of Legal Consequences for Heineken If this isn't a financial wake-up call for the brewing giant, I don't know what is. In the latest twist of corporate accountability, the Amsterdam District Court has ordered Heineken and its Greek subsidiary, Athenian Brewery, to cough up a whopping €111 million. And we're not just talking pocket change—this ruling speaks...

Eightpoint Backs Community Shelter with Vital Aid

Eightpoint Technologies Steps Up for a Crucial Cause Kicking in when it counts, Eightpoint Technologies has done something that might not turn stock market heads but speaks volumes about corporate responsibility. They're ponying up for a year's worth of groceries for the Cayman Islands Crisis Centre (CICC) starting November 1, 2026. We're talking real relief for women and...

Bose Grabs Skullcandy: A Bold Audio Acquisition Move

Bose Broadens Horizons with Skullcandy Acquisition Well, here's a twist that rattles my morning coffee mug: Bose goes and buys Skullcandy. That’s right, the audio bigwig known for polished sound just snapped up the edgier, younger sibling in earbuds. Bose ain't just playing with sound anymore; they're grabbing lifestyle by the horns, hoping Skullcandy's flair will shake...